Overview
Anjali Rohatgi is a Hematologist practicing medicine in Saint Peters, Missouri.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
She is actively involved in clinical research, co-authoring 13 peer reviewed articles. Dr. Rohatgi is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
150 Entrance Way, Saint Peters, MO 63376
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
SSM Health Cancer Care
"Dr. Zoghbi is an experience board-certified medical oncologist and hematologist who has been in practice since 2011. A graduate of Lebanese University School of Medicine in Lebanon, Dr. Zoghbi completed her residency at East Tennessee State University. She is fellowship trained in hematology, oncology and bone marrow transplant from Saint Louis University. Dr. Zoghbi treats patients aged 18 years and older. She is highly trained and qualified to treat a broad range of diseases, but takes a special interest in treating people with breast cancer, colon cancer, lung cancer and prostate cancer. She also sees other solid tumors as well as benign and malignant hematologic disorders (e.g. iron deficiency anemia , lymphoma, myeloma, and chronic leukemia (CLL, CML). Dr. Zoghbi is fluent in English, French and Arabic. She is a member of the American Society of Clinical Oncologists (ASCO) and the American Society of Hematologists (ASH). ""My goal is to deliver the state-of-the-art, most advanced therapies to my patients while focusing on maintaining good quality of life. I am dedicated to diagnose, treat and prevent different types of cancers. Providing education and high compassionate care are the cornerstones in treating my patients.""". Dr. Zoghbi is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Colorectal Cancer, and Breast Cancer. Dr. Zoghbi is board certified in Missouri Dept Of Health/Narcotics&Dangerous Drugs , American Board Of Internal Medicine/Hematology , American Board Of Internal Medicine/Medical Oncology , Missouri State Board Of Registration, American Board Of Internal Medicine , and Drug Enforcement Administration . Dr. Zoghbi is currently accepting new patients.
SSM Health Cancer Care
Board Certified medical oncologist and hematologist with expertise in treating breast cancer, lung cancer, colorectal cancer, prostate cancer, renal and bladder cancer, head and neck cancer, lymphomas, and other hematologic malignancies. Dr. Zvinovski is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Breast Cancer. Dr. Zvinovski is board certified in Hematology, Medical Oncology, and Internal Medicine. Dr. Zvinovski is currently accepting new patients.
SSM Health Cancer Care
"Dr. Ayalew is board-certified in internal medicine, hematology and medical oncology. He is a member of the American Societies of Hematology and Clinical Oncology as well as the American College of Physicians. He received his medical degree from Gondar College of Medical sciences, Ethiopia and completed his residency and fellowship at the SUNY Downstate Medical Center in New York where he also became the chief fellow. Dr. Ayalew treats patients from 18 years and older and is excited to bring his expertise to the SSM Cancer Care team. ""Dealing with cancer can be a difficult journey for patients and their families. As a Hematologist and Oncologist, my goal is to optimize the quality of life for my patients and their loved ones, helping them cope with these challenges. I understand that every patient has unique needs, and I tailor practice decisions to individual patients by incorporating the latest evidence based medicine.""-Getinet Ayalew, MD". Dr. Ayalew is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Ayalew is board certified in American Board Of Internal Medicine/Hematology , Missouri Dept Of Health/Narcotics&Dangerous Drugs , American Board Of Internal Medicine/Medical Oncology , Missouri State Board Of Registration, and Drug Enforcement Administration . Dr. Ayalew is currently accepting new patients.
The Siteman Cancer Center Medical Oncology
Peter Oppelt is a Hematologist and an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Oppelt is highly rated in 58 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Adult Soft Tissue Sarcoma, Laryngeal Cancer, Alveolar Soft Part Sarcoma, and Gastrostomy. Dr. Oppelt is currently accepting new patients.
St. Luke's Center For Cancer Care
Mark Fesler is a Hematologist and an Oncologist practicing medicine in Chesterfield, Missouri. Dr. Fesler is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Transplant. Dr. Fesler is currently accepting new patients.
St. Luke's Center For Cancer Care
Elliot Abbey is a Hematologist and an Oncologist practicing medicine in Chesterfield, Missouri. Dr. Abbey is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Abbey is currently accepting new patients.
Frequently Asked Questions about Dr. Anjali Rohatgi
How do I make an appointment with Dr. Anjali Rohatgi?
You can book an appointment with Dr. Anjali Rohatgi by calling their office at 636-916-9920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Anjali Rohatgi a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anjali Rohatgi is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Anjali Rohatgi specialize in?
While Dr. Anjali Rohatgi is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Anjali Rohatgi participate in research or clinical trials?
Yes. Dr. Anjali Rohatgi has published 13 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Anjali Rohatgi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Anjali Rohatgi accept my insurance?
Dr. Anjali Rohatgi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 636-916-9920 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Rohatgi isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.


